LTF and glioma: Shikonin faces difficulty traversing the blood–brain barrier, but Li et al. [60] devised PEG-PLGA nanoparticles coated with lactoferrin to enhance their ability to cross the blood–brain barrier and reach receptor-mediated pathway targets on glioma cells.